Profile of romosozumab and its potential in the management of osteoporosis.
about
Osteoporosis treatment: recent developments and ongoing challenges.Musculoskeletal Health in the Context of Spinal Cord Injury.R-spondin-2 is a Wnt agonist that regulates osteoblast activity and bone massChanges in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study
P2860
Profile of romosozumab and its potential in the management of osteoporosis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Profile of romosozumab and its potential in the management of osteoporosis.
@ast
Profile of romosozumab and its potential in the management of osteoporosis.
@en
type
label
Profile of romosozumab and its potential in the management of osteoporosis.
@ast
Profile of romosozumab and its potential in the management of osteoporosis.
@en
prefLabel
Profile of romosozumab and its potential in the management of osteoporosis.
@ast
Profile of romosozumab and its potential in the management of osteoporosis.
@en
P2860
P921
P356
P1476
Profile of romosozumab and its potential in the management of osteoporosis.
@en
P2093
Marcy B Bolster
Sian Yik Lim
P2860
P304
P356
10.2147/DDDT.S127568
P407
P5008
P577
2017-04-13T00:00:00Z